First Trust NYSE Arca Biotechnology Index Fund (FBT)

First Trust NYSE Arca Biotechnology Index Fund (FBT) is listed on NYSE Arca, where it has traded since June 19, 2006.

Listed On
NYSE Arca
Listed Since
June 19, 2006

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 339 institutions reported holding FBT, with 8.1 million shares worth $2.0 billion in aggregate. The largest reported holder was First Trust Advisors, with 3.4 million shares worth $840.0 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
First Trust Advisors3,388,725$840MReduced 3.6%
Morgan Stanley545,436$135MAdded 2.1%
Wells Fargo & Company/MN444,334$110MAdded 4.25%
Lpl Financial258,714$64MReduced 12.5%
Raymond James Financial221,361$55MAdded 9.11%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is FBT?

First Trust NYSE Arca Biotechnology Index Fund (FBT) is listed on NYSE Arca, where it has traded since June 19, 2006.

Who are the largest institutional holders of FBT?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of FBT were First Trust Advisors, Morgan Stanley and Wells Fargo & Company/MN.

How many institutions own FBT?

339 institutions reported a position in FBT for the quarter ended June 30, 2026, worth $2.0 billion in total.

Did institutions buy or sell FBT last quarter?

Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for FBT.

Every reported institutional holder, plus insider and congressional trades in FBT, on SentiSense.